BackAMAG Pharmaceuticals Overview

AMAG Pharmaceuticals Net Tangible Assets

AMAG Pharmaceuticals's net tangible assets is $-170M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$-168.46M
↑ 30.13% YoYΔ $-39.00M vs prior year quarter

Peer trimmed avg / median

Loading

AMAG Pharmaceuticals Net Tangible Assets History

Loading

AMAG Pharmaceuticals vs. peers: Net Tangible Assets Comparison

Loading

AMAG Pharmaceuticals Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

AMAG Pharmaceuticals (AMAG) FAQ

As of the most recent data (September 2020), AMAG shows a net tangible assets of $-170M. That compares with $-130M in the prior-year period — down 30.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AMAG's net tangible assets is now $-170M (was $-130M) — a 30.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether AMAG Pharmaceuticals is outperforming or lagging.

Tracking AMAG's net tangible assets over time shows whether AMAG Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $-170M That compares with $-130M in the prior-year period — down 30.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has AMAG Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $-170M) with ownership activity and broader fundamentals.

AMAG Pharmaceuticals's net tangible assets is $-170M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.